PRESSRELEASES

1 October, 2025

Nanexa AB changes Certified Adviser to Tapper Partners AB

Nanexa AB announces today that the company is changing its Certified Adviser to Tapper Partners AB.

READ MORE

22 September, 2025

Nanexa receives Japanese patent approval for specific PharmaShell structure

The approval strengthens Nanexa’s patent portfolio, with additional patent applications filed in other strategically important countries

READ MORE

LATEST REPORTS

27 August, 2025

Nanexa publishes interim report for January-June 2025

Download attachment

6 May, 2025

Nanexa publishes interim report for January-March 2025

Download attachment

PRESENTATIONS

27 August 2025

Q2 report commentary with CEO David Westberg

22 June 2025

Poster presented at American Diabetes Association (ADA), 22 June

View poster

16 June 2025

Interview with CEO David Westberg from The Pharma Navigator

3 June 2025

DDF Summit, Drug Delivery & Formulation i Berlin

Read the presentation

MEET NANEXA

27 - 28 Oct, 2025

PODD, Boston. Meet David Westberg CEO & Bridget Lacey, CBO

28 - 30 Oct, 2025

CPHI, Frankfurt. Meet Mårten Rooth, CTO.

PRENUMERERA